87 related articles for article (PubMed ID: 2537066)
1. Tamoxifen withdrawal response. Report of a case.
Belani CP; Pearl P; Whitley NO; Aisner J
Arch Intern Med; 1989 Feb; 149(2):449-50. PubMed ID: 2537066
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen-induced tumor stimulation and withdrawal response.
Legault-Poisson S; Jolivet J; Poisson R; Beretta-Piccoli M; Band PR
Cancer Treat Rep; 1979; 63(11-12):1839-41. PubMed ID: 230894
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
[TBL] [Abstract][Full Text] [Related]
4. [A case of brain metastasis from breast cancer responding to chemoendocrine therapy].
Nomizu T; Watanabe F; Honda K; Kanazawa M; Yamaki Y; Tsuchiya A; Abe R
Gan No Rinsho; 1990 Dec; 36(15):2594-8. PubMed ID: 2176248
[TBL] [Abstract][Full Text] [Related]
5. Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman. A case report.
Jolles CJ; Smotkin D; Ford KL; Jones KP
J Reprod Med; 1990 Mar; 35(3):299-300. PubMed ID: 2157841
[TBL] [Abstract][Full Text] [Related]
6. [The estrogen receptor in breast carcinoma in male patients and the tamoxifen response].
Gómez Cruz P; Rivadeneyra Hinojosa J; García-Alonso H; Rábago Velasco M
Ginecol Obstet Mex; 1988 Nov; 56():310-4. PubMed ID: 2856451
[No Abstract] [Full Text] [Related]
7. [A case of recurrent breast cancer responding to long-term administration of tamoxifen].
Yayoi E; Kobayashi T; Inaji H; Maeura Y; Mori T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1683-6. PubMed ID: 6433801
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer.
Beex L; Pieters G; Smals A; Koenders A; Benraad T; Kloppenborg P
Cancer Treat Rep; 1981; 65(3-4):179-85. PubMed ID: 7237448
[TBL] [Abstract][Full Text] [Related]
9. [A case of breast cancer with metastasis of multiple organs showing marked efficacy of medroxyprogesterone acetate (MPA)].
Shimada K; Karaki Y; Ansai Y; Hino K; Yamashita Y; Fujimaki M
Gan To Kagaku Ryoho; 1996 Apr; 23(5):623-6. PubMed ID: 8678522
[TBL] [Abstract][Full Text] [Related]
10. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
Yen TW; Hunt KK; Mirza NQ; Thomas ES; Singletary SE; Babiera GV; Meric-Bernstam F; Buchholz TA; Feig BW; Ross MI; Ames FC; Theriault RL; Kuerer HM
Cancer; 2004 Mar; 100(5):942-9. PubMed ID: 14983489
[TBL] [Abstract][Full Text] [Related]
11. [A case report of advanced breast cancer effectively treated by chemo-endocrine therapy with diethylstilbestrol diphosphate and cyclophosphamide].
Hareyama M; Saito A; Oouchi A; Morita K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2453-6. PubMed ID: 2751322
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen and hypercalcaemia. A case report.
Bezwoda WR; Derman D; Zaltzman M; de Moor NG; Lange M
S Afr Med J; 1980 Nov; 58(20):821-2. PubMed ID: 6255614
[TBL] [Abstract][Full Text] [Related]
13. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
14. [A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
Rai Y; Emi Y; Nishijima N; Kai S; Kano T
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1475-8. PubMed ID: 10500537
[TBL] [Abstract][Full Text] [Related]
15. [Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications].
Mauriac L; Durand M; Bonichon F; Chauvergne J
Bull Cancer; 1986; 73(2):148-54. PubMed ID: 2942203
[TBL] [Abstract][Full Text] [Related]
16. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
Fargeot P; Bonneterre J; Roché H; Lortholary A; Campone M; Van Praagh I; Monnier A; Namer M; Schraub S; Barats JC; Guastalla JP; Goudier MJ; Chapelle-Marcillac I
J Clin Oncol; 2004 Dec; 22(23):4622-30. PubMed ID: 15505276
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.
Singletary SE; Atkinson EN; Hoque A; Sneige N; Sahin AA; Fritsche HA; Lotan R; Lu T; Hittelman WN; Bevers TB; Stelling CB; Lippman SM
Clin Cancer Res; 2002 Sep; 8(9):2835-42. PubMed ID: 12231524
[TBL] [Abstract][Full Text] [Related]
18. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
[TBL] [Abstract][Full Text] [Related]
19. [A case of aged recurrent breast cancer with multiple lung metastases responding to examestane monotherapy].
Imamura S; Aso M; Sakata H; Katoh H
Gan To Kagaku Ryoho; 2006 Mar; 33(3):361-4. PubMed ID: 16531719
[TBL] [Abstract][Full Text] [Related]
20. Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study.
Milla-Santos A; Milla L; Portella J; Rallo L; Pons M; Rodes E; Casanovas J; Puig-Gali M
Am J Clin Oncol; 2003 Jun; 26(3):317-22. PubMed ID: 12796608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
